Tue, 20 December 2016
A QC Lunch & Learn Webinar with Nathan Morse, Maine state coordinator of the National Diabetes Prevention Program.
Interested in referring your patients with prediabetes to evidence-based lifestyle change programs that will soon be a reimbursable service? Here in Maine, the National Diabetes Prevention Program (NDPP) is partnering with health systems, primary care practices, and community-based organizations to do just that – and more. Join us for this webinar with Nathan Morse, supervisor of the Maine CDC’s Diabetes Unit and the State of Maine coordinator of the NDPP. He’ll discuss the cross-cutting effects of primary prevention for chronic diseases and delve into the NDPP history, successes , tools and opportunities for partnership.
Tue, 13 December 2016
Prescription drug and opioid overdoses continue to rise in Maine and in the United States as a whole. Communities with Overdose Education and Naloxone Distribution (OEND) programs have demonstrated how effective naloxone prescribing can be in the number of lives reported to have been saved. This webinar will explore how to prescribe naloxone, how to talk to patients about the importance of having and knowing how to use naloxone and how to access naloxone affordably. Elisabeth Fowlie Mock, MD, will present. Elisabeth regularly teaches providers about naloxone use and other opioid-related clinical topics for MICIS, the Maine Medical Association’s academic detailing program.
Direct download: LL_12-13-16_audio_only.m4a
Category:HealthCare, Maine Quality Counts, MQC, Naloxone, Opioid Use Disorder, Overdose Education -- posted at: 1:22pm EDT
Wed, 7 December 2016
As the incidence of multiple chronic diseases increases among older patients, so does the phenomenon of polypharmacy. Forty percent of community-dwelling older adults take five or more medications per day. Fifty percent of nursing home residents take nine or more. And in the inpatient setting, the rates are even higher.
According to the DHHS, “the burden of taking multiple medications has been associated with greater health care costs and an increased risk of adverse drug events, drug-interactions, medication non-adherence, reduced functional capacity and multiple geriatric syndromes.”
In this webinar, we present “person-centered deprescribing,” a new approach to reducing medication burden that a 2014 British Journal of Clinical Pharmacology article hails “as the first deprescribing process developed using knowledge of the patients' views of medication cessation; it focuses on engaging patients throughout the process, with the aim of improving long-term health outcomes.”
Please join presenters Dr. Roger Renfrew and Dr. Mary Ann E. Zagaria to explore the elements and benefits of person-centered deprescribing.